Compounded glutathione recalled over elevated endotoxin levels
October 1, 2026
AI summary — for doctors, generated from the source snippet
Why it matters
Greenwich Rx is recalling specific lots of compounded glutathione to the consumer level because of elevated endotoxin.
Clinical relevance
Be alert for patients who received injectable compounded glutathione from this pharmacy.
Who should care
This is an AI-generated summary of the source's own press release/snippet, not a clinical recommendation. Verify against the original source before acting on it.
Original source summary
IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
Verbatim from FDA MedWatch Safety Alerts's own feed — "Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news